{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    7,
    9
  ],
  "modelUsed": "gemini-3-flash-preview",
  "advanced": {
    "studyAmendments": [
      {
        "id": "amend_1",
        "number": "a",
        "name": "Amendment a",
        "scope": {
          "id": "0b932305-419f-4e04-9073-43e9d609dfa5",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "a4537ed2-bb9c-47d5-80d7-07bd4427039f",
          "code": {
            "id": "4ddee7d6-8261-47dc-89bd-583ce3f920bd",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "a64a27cb-d837-48ef-99a1-3fb54994084c",
            "type": {
              "id": "9292c514-4c82-4b1a-88c8-921f0a1b9b2d",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "A Phase 3 Study of Nasal Glucagon (LY900018) Compared to Intramuscular Glucagon for Treatment of Insulin-induced Hypoglycemia in Japanese Patients with Diabetes Mellitus.",
        "effectiveDate": "2017-12-05",
        "reasonIds": [
          "ar_1_1",
          "ar_1_2"
        ],
        "previousVersion": "Original Protocol",
        "newVersion": "Amendment (a)"
      }
    ],
    "amendmentReasons": [
      {
        "id": "ar_1_1",
        "code": "SCIENTIFIC",
        "description": "Scientific",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_1_2",
        "code": "REGULATORY",
        "description": "Regulatory",
        "instanceType": "AmendmentReason"
      }
    ],
    "countries": [
      {
        "id": "country_1",
        "name": "Japan",
        "instanceType": "Country",
        "code": "JP"
      }
    ],
    "studySites": [],
    "summary": {
      "amendmentCount": 1,
      "countryCount": 1,
      "siteCount": 0
    },
    "geographicScope": {
      "id": "geo_1",
      "name": "Study Geographic Scope",
      "scopeType": "Regional",
      "instanceType": "GeographicScope",
      "countryIds": [
        "country_1"
      ],
      "regions": [
        "Asia"
      ]
    }
  },
  "rawResponse": {
    "amendments": [
      {
        "number": "a",
        "effectiveDate": "2017-12-05",
        "summary": "A Phase 3 Study of Nasal Glucagon (LY900018) Compared to Intramuscular Glucagon for Treatment of Insulin-induced Hypoglycemia in Japanese Patients with Diabetes Mellitus.",
        "previousVersion": "Original Protocol",
        "newVersion": "Amendment (a)",
        "reasons": [
          "Scientific",
          "Regulatory"
        ]
      }
    ],
    "geographicScope": {
      "type": "Regional",
      "countries": [
        {
          "name": "Japan",
          "code": "JP"
        }
      ],
      "regions": [
        "Asia"
      ],
      "plannedSites": null
    },
    "sites": []
  }
}